Aging and the treatment of basal cell carcinoma
We describe how a patient ’s life expectancy can be estimated and combined with tumor characteristics to determine lag time to benefit, a concept to better understand whether patients will experience the efficacy of a treatment within their life span.
Source: Clinics in Dermatology - Category: Dermatology Authors: Shreya Sreekantaswamy, Justin Endo, Amy Chen, Daniel Butler, Lily Morrison, Eleni Linos Source Type: research
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Dermatology | Geriatrics | Skin | Skin Cancer